DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity

Cheng Tao Lin, Ya Chea Tsai, Liangmei He, Chun Nan Yeh, Ting Chang Chang, Yung Kuei Soong, Archana Monie, Chien-Fu Hung, Chyong Huey Lai

Research output: Contribution to journalArticle

Abstract

DNA vaccination has emerged as a promising strategy for cancer immunotherapy. However, since DNA vaccines have low immunogenicity, various strategies have been developed to enhance the potency of DNA vaccines. In the current study, we aim to determine whether the potency of the DNA vaccine encoding human papillomavirus type 16 (HPV-16) E7 antigen can be enhanced by IL-2. We have generated a DNA vaccine encoding IL-2 linked to HPV-16 E7 antigen. Our results indicate that the DNA vaccine encoding a fusion of IL-2 and E7 proteins generated the highest frequency of E7-specific CD8+ T cells. We also found that the DNA vaccine encoding a fusion of IL-2 and E7 proteins generated the strongest protective as well as therapeutic anti-tumor effect against E7-expressing tumors. In addition, it was observed that CD8+ T cells were mainly responsible for the antitumor effect generated by the DNA vaccine encoding a fusion of IL-2 and E7 proteins. Thus, we conclude that the linkage of IL-2 to HPV-16 E7 antigen significantly enhances the DNA vaccine potency against E7-expressing tumors. Our strategy may potentially be used in other antigenic systems to control infectious diseases and/or cancer.

Original languageEnglish (US)
Pages (from-to)86-93
Number of pages8
JournalImmunology Letters
Volume114
Issue number2
DOIs
StatePublished - Dec 15 2007

Fingerprint

DNA Vaccines
Human papillomavirus 16
Interleukin-2
Antigens
Vaccine Potency
Neoplasms
T-Lymphocytes
Proteins
Immunotherapy
Communicable Diseases
Vaccination
DNA

Keywords

  • DNA vaccine
  • E7
  • HPV
  • IL-2

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity. / Lin, Cheng Tao; Tsai, Ya Chea; He, Liangmei; Yeh, Chun Nan; Chang, Ting Chang; Soong, Yung Kuei; Monie, Archana; Hung, Chien-Fu; Lai, Chyong Huey.

In: Immunology Letters, Vol. 114, No. 2, 15.12.2007, p. 86-93.

Research output: Contribution to journalArticle

Lin, Cheng Tao ; Tsai, Ya Chea ; He, Liangmei ; Yeh, Chun Nan ; Chang, Ting Chang ; Soong, Yung Kuei ; Monie, Archana ; Hung, Chien-Fu ; Lai, Chyong Huey. / DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity. In: Immunology Letters. 2007 ; Vol. 114, No. 2. pp. 86-93.
@article{6efa43cc2bc04c2d81bd3977385cfbb6,
title = "DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity",
abstract = "DNA vaccination has emerged as a promising strategy for cancer immunotherapy. However, since DNA vaccines have low immunogenicity, various strategies have been developed to enhance the potency of DNA vaccines. In the current study, we aim to determine whether the potency of the DNA vaccine encoding human papillomavirus type 16 (HPV-16) E7 antigen can be enhanced by IL-2. We have generated a DNA vaccine encoding IL-2 linked to HPV-16 E7 antigen. Our results indicate that the DNA vaccine encoding a fusion of IL-2 and E7 proteins generated the highest frequency of E7-specific CD8+ T cells. We also found that the DNA vaccine encoding a fusion of IL-2 and E7 proteins generated the strongest protective as well as therapeutic anti-tumor effect against E7-expressing tumors. In addition, it was observed that CD8+ T cells were mainly responsible for the antitumor effect generated by the DNA vaccine encoding a fusion of IL-2 and E7 proteins. Thus, we conclude that the linkage of IL-2 to HPV-16 E7 antigen significantly enhances the DNA vaccine potency against E7-expressing tumors. Our strategy may potentially be used in other antigenic systems to control infectious diseases and/or cancer.",
keywords = "DNA vaccine, E7, HPV, IL-2",
author = "Lin, {Cheng Tao} and Tsai, {Ya Chea} and Liangmei He and Yeh, {Chun Nan} and Chang, {Ting Chang} and Soong, {Yung Kuei} and Archana Monie and Chien-Fu Hung and Lai, {Chyong Huey}",
year = "2007",
month = "12",
day = "15",
doi = "10.1016/j.imlet.2007.09.008",
language = "English (US)",
volume = "114",
pages = "86--93",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity

AU - Lin, Cheng Tao

AU - Tsai, Ya Chea

AU - He, Liangmei

AU - Yeh, Chun Nan

AU - Chang, Ting Chang

AU - Soong, Yung Kuei

AU - Monie, Archana

AU - Hung, Chien-Fu

AU - Lai, Chyong Huey

PY - 2007/12/15

Y1 - 2007/12/15

N2 - DNA vaccination has emerged as a promising strategy for cancer immunotherapy. However, since DNA vaccines have low immunogenicity, various strategies have been developed to enhance the potency of DNA vaccines. In the current study, we aim to determine whether the potency of the DNA vaccine encoding human papillomavirus type 16 (HPV-16) E7 antigen can be enhanced by IL-2. We have generated a DNA vaccine encoding IL-2 linked to HPV-16 E7 antigen. Our results indicate that the DNA vaccine encoding a fusion of IL-2 and E7 proteins generated the highest frequency of E7-specific CD8+ T cells. We also found that the DNA vaccine encoding a fusion of IL-2 and E7 proteins generated the strongest protective as well as therapeutic anti-tumor effect against E7-expressing tumors. In addition, it was observed that CD8+ T cells were mainly responsible for the antitumor effect generated by the DNA vaccine encoding a fusion of IL-2 and E7 proteins. Thus, we conclude that the linkage of IL-2 to HPV-16 E7 antigen significantly enhances the DNA vaccine potency against E7-expressing tumors. Our strategy may potentially be used in other antigenic systems to control infectious diseases and/or cancer.

AB - DNA vaccination has emerged as a promising strategy for cancer immunotherapy. However, since DNA vaccines have low immunogenicity, various strategies have been developed to enhance the potency of DNA vaccines. In the current study, we aim to determine whether the potency of the DNA vaccine encoding human papillomavirus type 16 (HPV-16) E7 antigen can be enhanced by IL-2. We have generated a DNA vaccine encoding IL-2 linked to HPV-16 E7 antigen. Our results indicate that the DNA vaccine encoding a fusion of IL-2 and E7 proteins generated the highest frequency of E7-specific CD8+ T cells. We also found that the DNA vaccine encoding a fusion of IL-2 and E7 proteins generated the strongest protective as well as therapeutic anti-tumor effect against E7-expressing tumors. In addition, it was observed that CD8+ T cells were mainly responsible for the antitumor effect generated by the DNA vaccine encoding a fusion of IL-2 and E7 proteins. Thus, we conclude that the linkage of IL-2 to HPV-16 E7 antigen significantly enhances the DNA vaccine potency against E7-expressing tumors. Our strategy may potentially be used in other antigenic systems to control infectious diseases and/or cancer.

KW - DNA vaccine

KW - E7

KW - HPV

KW - IL-2

UR - http://www.scopus.com/inward/record.url?scp=36549019001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36549019001&partnerID=8YFLogxK

U2 - 10.1016/j.imlet.2007.09.008

DO - 10.1016/j.imlet.2007.09.008

M3 - Article

C2 - 17976741

AN - SCOPUS:36549019001

VL - 114

SP - 86

EP - 93

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 2

ER -